JP2010047616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010047616A5 JP2010047616A5 JP2009274999A JP2009274999A JP2010047616A5 JP 2010047616 A5 JP2010047616 A5 JP 2010047616A5 JP 2009274999 A JP2009274999 A JP 2009274999A JP 2009274999 A JP2009274999 A JP 2009274999A JP 2010047616 A5 JP2010047616 A5 JP 2010047616A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- disease
- subject
- alzheimer
- coa reductase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010001897 Alzheimer's disease Diseases 0.000 claims 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 2
- FJLGEFLZQAZZCD-JUFISIKESA-N (3S,5R)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-JUFISIKESA-N 0.000 claims 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims 1
- SEERZIQQUAZTOL-ANMDKAQQSA-N Cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N Lovastatin Chemical group C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- AJLFOPYRIVGYMJ-INTXDZFKSA-N Mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims 1
- 229960002965 Pravastatin Drugs 0.000 claims 1
- TUZYXOIXSAXUGO-PZAWKZKUSA-N Pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 1
- RYMZZMVNJRMUDD-HGQWONQESA-N Simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 claims 1
- 229960005370 atorvastatin Drugs 0.000 claims 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims 1
- 229960005110 cerivastatin Drugs 0.000 claims 1
- 229960003765 fluvastatin Drugs 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- 210000002569 neurons Anatomy 0.000 claims 1
- 229960002855 simvastatin Drugs 0.000 claims 1
Claims (3)
- アルツハイマー病の危険があるか、またはアルツハイマー病と診断された被験体において、アルツハイマー病を処置または予防するための組成物であって、該組成物は、該被験体の神経細胞においてアミロイドβの産生を阻害するために有効な量のHMG CoAレダクターゼインヒビターを含む、組成物。
- 前記HMG CoAレダクターゼインヒビターが、ロバスタチン、シンバスタチン、フルバスタチン、プラバスタチン、アトルバスタチン、セリバスタチンおよびコンパクチンからなる群より選択される、請求項1に記載の組成物。
- 前記被験体に経口投与されることを特徴とする、請求項1または2に記載の組成物。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/046,235 US6080778A (en) | 1998-03-23 | 1998-03-23 | Methods for decreasing beta amyloid protein |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000537538A Division JP2002507564A (ja) | 1998-03-23 | 1999-03-23 | βアミロイドタンパク質を減少させるための方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010047616A JP2010047616A (ja) | 2010-03-04 |
JP2010047616A5 true JP2010047616A5 (ja) | 2010-10-14 |
Family
ID=21942345
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000537538A Pending JP2002507564A (ja) | 1998-03-23 | 1999-03-23 | βアミロイドタンパク質を減少させるための方法 |
JP2009274999A Pending JP2010047616A (ja) | 1998-03-23 | 2009-12-02 | βアミロイドタンパク質を減少させるための方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000537538A Pending JP2002507564A (ja) | 1998-03-23 | 1999-03-23 | βアミロイドタンパク質を減少させるための方法 |
Country Status (6)
Country | Link |
---|---|
US (5) | US6080778A (ja) |
EP (1) | EP1063980A2 (ja) |
JP (2) | JP2002507564A (ja) |
AU (1) | AU759257B2 (ja) |
CA (1) | CA2324999A1 (ja) |
WO (1) | WO1999048488A2 (ja) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072138A1 (en) * | 1997-11-25 | 2004-04-15 | Medical University Of South Carolina | Attenuation of ischemia/reperfusion injury |
WO1999026657A1 (en) * | 1997-11-25 | 1999-06-03 | Musc Foundation For Research Development | Inhibitors of nitric oxide synthase |
US20080275104A1 (en) * | 1997-11-25 | 2008-11-06 | Musc Foundation For Research Development | Methods of treating juvenile type 1 diabetes mellitus |
US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
US20020188012A1 (en) * | 1998-01-28 | 2002-12-12 | Bisgaier Charles Larry | Method for treating Alzheimer's disease |
US6472421B1 (en) * | 1998-11-13 | 2002-10-29 | Nymox Corporation | Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor |
JP2002530122A (ja) * | 1998-11-25 | 2002-09-17 | サイオス インコーポレイテッド | アミロイド関連疾患の予防及び治療 |
US20020055529A1 (en) * | 1998-12-02 | 2002-05-09 | Bisgaier Charles Larry | Method for treating alzheimer's disease |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
JP2003523948A (ja) * | 1999-11-04 | 2003-08-12 | アンドルクス コーポレーション | アミロイドβ前駆体障害の治療法 |
AR027878A1 (es) * | 1999-11-05 | 2003-04-16 | Wyeth Corp | Metodos para identificar y utilizar compuestos inhibidores de amiloides |
US20010028895A1 (en) * | 2000-02-04 | 2001-10-11 | Bisgaier Charles L. | Methods of treating alzheimer's disease |
US7407662B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified viral particles with immunogenic properties and reduced lipid content |
US20090017069A1 (en) * | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
US7407663B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified immunodeficiency virus particles |
US7439052B2 (en) * | 2000-06-29 | 2008-10-21 | Lipid Sciences | Method of making modified immunodeficiency virus particles |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
EP1366061A4 (en) * | 2001-02-05 | 2006-04-26 | Andrx Corp | METHOD FOR TREATING BETA AMYLOID PRECURSOR ILLNESSES |
US20020173535A1 (en) * | 2001-02-07 | 2002-11-21 | Renshaw Perry F. | Cholesterol-lowering agents as treatment for psychological and cognitive disorders |
WO2002100836A2 (en) * | 2001-06-12 | 2002-12-19 | Active Pass Pharmaceuticals, Inc. | Compounds, compositions and methods for modulating beta-amyloid production |
US20030191144A1 (en) * | 2001-06-12 | 2003-10-09 | Active Pass Pharmaceuticals, Inc. | Compounds, compositions and methods for modulating beta-amyloid production |
US6991727B2 (en) * | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
US20060060520A1 (en) * | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
WO2003000372A2 (en) * | 2001-06-25 | 2003-01-03 | Lipid Sciences, Inc. | Systems and methods using multiple solvents for the removal of lipids from fluids |
EP1409108A4 (en) * | 2001-06-25 | 2007-11-14 | Lipid Sciences Inc | HOLLOW FIBER CONTACTOR SYSTEMS FOR THE REMOVAL OF LIPIDS FROM LIQUIDS |
CA2451633C (en) * | 2001-06-25 | 2010-11-30 | Lipid Sciences, Inc. | Systems and methods using a solvent for the removal of lipids from fluids |
AU2003218004A1 (en) * | 2002-03-12 | 2003-09-29 | Merck & Co., Inc. | Drug combination therapy |
US20050222122A1 (en) * | 2002-04-02 | 2005-10-06 | Sean Lilienfeld | Statin therapy for enhancing cognitive maintenance |
WO2004009527A1 (en) * | 2002-07-19 | 2004-01-29 | Aryx Therapeutics | Materials and methods for treating hypercholesterolemia |
JP2005538148A (ja) * | 2002-08-26 | 2005-12-15 | リピド サイエンスィズ インコーポレイテッド | 脱脂タンパク質粒子を使用したアルツハイマー病治療 |
FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
MXPA05009502A (es) * | 2003-03-07 | 2005-10-18 | Schering Corp | Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
JP4589919B2 (ja) * | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
ATE406364T1 (de) | 2003-03-07 | 2008-09-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
KR20050110017A (ko) * | 2003-03-17 | 2005-11-22 | 니뽄 다바코 산교 가부시키가이샤 | S-'2-(''1-(2-에틸부틸)시클로헥실!카르보닐!아미노)페닐!-2-메틸프로판티오에이트의 경구 생체이용율을증가시키는 방법 |
PL1603553T3 (pl) * | 2003-03-17 | 2012-04-30 | Japan Tobacco Inc | Kompozycje farmaceutyczne inhibitorów CETP |
TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
AU2004260632A1 (en) * | 2003-07-03 | 2005-02-10 | Lipid Sciences Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
US20050113458A1 (en) * | 2003-10-22 | 2005-05-26 | Forest Laboratories, Inc. | Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathies |
US6960803B2 (en) * | 2003-10-23 | 2005-11-01 | Silicon Storage Technology, Inc. | Landing pad for use as a contact to a conductive spacer |
JP2007516294A (ja) * | 2003-12-23 | 2007-06-21 | エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント | 炎症性の疾患または症状の予防および治療のための方法および組成物 |
US20070161700A1 (en) * | 2004-12-28 | 2007-07-12 | Kowa Company, Ltd. | Inhibitor for the formation of y-secretase complex |
JPWO2005094814A1 (ja) * | 2004-03-31 | 2008-02-14 | 興和株式会社 | 外用剤 |
WO2005123955A2 (en) * | 2004-06-09 | 2005-12-29 | Children's Medical Center Corporation | Methods and compositions for modifying gene regulation and dna damage in ageing |
US20060039890A1 (en) * | 2004-08-20 | 2006-02-23 | Renshaw Perry F | Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant |
US8353184B2 (en) * | 2005-01-21 | 2013-01-15 | Sinox Company Ltd. | Tamper indicating padlock |
CA2609980C (en) * | 2005-05-27 | 2015-10-13 | Queen's University At Kingston | Treatment of protein folding disorders |
US20100029654A1 (en) * | 2006-03-23 | 2010-02-04 | Mount Sinai School Of Medicine | Cardiovascular compositions and use of the same for the treatment of alzheimer's disease |
WO2008112887A1 (en) * | 2007-03-13 | 2008-09-18 | Musc Foundation For Research Development | Methods of treating juvenile type 1 diabetes mellitus |
TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
ES2330184B1 (es) * | 2008-06-03 | 2010-07-05 | Neuron Biopharma, S.A. | Uso de estatinas como anticonvulsivantes, antiepilepticos y neuroprotectores. |
US20120157419A1 (en) | 2009-02-02 | 2012-06-21 | Tuvia Gilat | Methods and compositions for treating alzheimer's disease |
KR102287877B1 (ko) * | 2014-03-13 | 2021-08-11 | 주식회사 하이폭시 | 차전자피를 포함하는 기억력 및 인지기능 증진용 조성물 |
US10821133B2 (en) | 2017-12-28 | 2020-11-03 | Hdl Therapeutics, Inc. | Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma |
CN111094537A (zh) * | 2017-09-08 | 2020-05-01 | 自然免疫制御技术研究组合 | 阿尔茨海默症诊断装置及方法 |
CN111868232B (zh) | 2017-11-22 | 2024-05-28 | Hdl治疗公司 | 用于对血浆处理系统的流体回路进行灌注的系统和方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
US4450171A (en) * | 1980-08-05 | 1984-05-22 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US5252471A (en) * | 1992-03-09 | 1993-10-12 | Merck & Co., Inc. | Directed biosynthesis of cholesterol lowering compounds |
WO1995006470A1 (en) * | 1993-08-30 | 1995-03-09 | Merck & Co., Inc. | Prevention and treatment of alzheimer's disease |
US6537987B1 (en) * | 1996-06-20 | 2003-03-25 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
US5929062A (en) * | 1997-06-19 | 1999-07-27 | University Of Western Ontario | Oxysterol inhibition of dietary cholesterol uptake |
CA2304505A1 (en) * | 1997-09-24 | 1999-04-01 | Nova Molecular, Inc. | Methods for increasing apoe levels for the treatment of neurodegenerative disease |
ES2257824T3 (es) * | 1998-01-28 | 2006-08-01 | Warner-Lambert Company Llc | Metodo para tratar la enfermedad de alzheimer. |
-
1998
- 1998-03-23 US US09/046,235 patent/US6080778A/en not_active Expired - Lifetime
-
1999
- 1999-01-28 US US09/239,387 patent/US6440387B1/en not_active Expired - Fee Related
- 1999-03-23 CA CA002324999A patent/CA2324999A1/en not_active Abandoned
- 1999-03-23 EP EP99914084A patent/EP1063980A2/en not_active Withdrawn
- 1999-03-23 JP JP2000537538A patent/JP2002507564A/ja active Pending
- 1999-03-23 AU AU32009/99A patent/AU759257B2/en not_active Ceased
- 1999-03-23 WO PCT/US1999/006396 patent/WO1999048488A2/en active IP Right Grant
-
2002
- 2002-02-28 US US10/086,398 patent/US20020120003A1/en not_active Abandoned
- 2002-07-14 US US10/198,331 patent/US20020183379A1/en not_active Abandoned
-
2005
- 2005-09-22 US US11/232,844 patent/US20060025469A1/en not_active Abandoned
-
2009
- 2009-12-02 JP JP2009274999A patent/JP2010047616A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010047616A5 (ja) | ||
RU2022100434A (ru) | Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения | |
JP2008532951A5 (ja) | ||
IL194949A0 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial | |
JP2010528011A5 (ja) | ||
SI1930002T1 (sl) | Uporaba estrov hidroksibenzojske kisline za izdelavo zdravila za preprečevanje in zdravljenje infekcije s HPV | |
BR112012006692B8 (pt) | composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato | |
JP2007530528A5 (ja) | ||
HK1157323A1 (en) | Compounds and compositions for the detection and treatment of alzheimers disease and related disorders | |
EA201401042A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И КОМБИНИРОВАННОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ ИНГИБИТОРЫ HMG-CoA-РЕДУКТАЗЫ И ФОСФОДИЭСТЕРАЗЫ 4, И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ ЛЕГКИХ | |
JP2022116083A5 (ja) | ||
CO6311069A2 (es) | Cápsulas que comprenden ácido acetilsalicílico, un inhibidor de la hmg-coa reductasa y un ace inhibidor para la prevención de enfermedades cardiovasculares | |
JP2016521279A5 (ja) | ||
JP2009537554A5 (ja) | ||
JP2006512361A5 (ja) | ||
CL2007003189A1 (es) | Compuestos derivados de indol y benzofurano; composicion farmaceutica; y uso para el tratamiento o la prevencion de la enfermedad de alzheimer. | |
EP2392335A3 (en) | Use of 24-norUDCA | |
JP2007512347A5 (ja) | ||
WO2009059717A3 (en) | Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use | |
EP2231148A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | |
GR20050100466A (el) | Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουναναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων | |
JP2008063322A5 (ja) | ||
GB0816269D0 (en) | Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of alzheimers disease | |
JP2006117645A5 (ja) | ||
WO2007020079A3 (en) | Orally disintegratable simvastatin tablets |